A genomic-based approach combining in vivo selection in mice to identify a novel virulence gene in Leishmania

PLoS Neglected Tropical Diseases

Volumn 2, Issue 6, 2008, Pages

  Zhang, Wen Wei ^a   Peacock, Christopher S ^b   Matlashewski, Greg ^a  

^a MCGILL UNIVERSITY   (Canada)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENOMICS; IN VIVO STUDY; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; MOLECULAR CLONING; MOUSE; NONHUMAN; PARASITE VIRULENCE; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; PSEUDOGENE; SEQUENCE ALIGNMENT; SPECIES DIFFERENCE; SPLEEN; TRANSGENE; VISCERAL LEISHMANIASIS; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; FLUORESCENCE MICROSCOPY; GENETICS; GENOME; METABOLISM; MOLECULAR GENETICS; NORTHERN BLOTTING; PATHOGENICITY; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SOUTHWESTERN BLOTTING; VIRULENCE; WESTERN BLOTTING;

PROTOZOAL PROTEIN;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, NORTHERN; BLOTTING, SOUTHWESTERN; BLOTTING, WESTERN; FEMALE; GENOME, PROTOZOAN; LEISHMANIA; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; VIRULENCE;

EID: 48949118080     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000248     Document Type: Article

References (27)

1. Herwaldt B (1999) Leishmaniasis. Lancet 354: 1191-1199.
2. Murray H, Berman J, Davis C, Saravia N (2005) Advances in Leishmaniasis. Lancet 366: 1561-1577.
3. Desjeux P (2001) The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 95: 239-243.
4. Lipoldova M, Demant P (2006) Genetic susceptibility to infectious disease: lesions from mouse models of leishruaniasis. Nat Rev Genet 7: 294-305.
5. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, et al. (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5: 873-82.
6. Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, et al. (2005) The genome of the kinetoplastid parasite, Lashmania major. Science 309: 436-442.
7. Peacock CS, Seeger K, Harris D, Murphy L, Ruiz JC, et al. (2007) Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nature Genetics 39: 839-847.
8. Smith DF, Peacock-CS, Cruz AK (2007) Comparative genomics: from genotype to disease phenotype in the leishmanisis. Int J Parasitol 37: 1173-86.
9. Charest H, Matlashewski G (1994) Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene. Mol Cell Biol 14: 2975-2984.
10. Ghedin E, Zhang WW, Charest H, Sundar S, Kenney RT, et al. (1997) Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis. Clin Diagn Lab Immunol 4: 530-535.
11. Zhang WW, Matlashewski G (1997) Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2. Proc Natl Acad Sci USA 94: 8807-8811.
12. Zhang WW, Matlashewski G (2001) Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection. Mol Microbiol 39: 935-948.
13. Zhang WW, Mendez S, Ghosh A, Myler P, Ivens A, et al. (2003) Comparison of the A2 gene locus in Leishmania donovani and L. major and its control over cutaneous infection. J Biol Chem 278: 35508-35515.
14. Zhang WW, Charest H, Madashewski G (1995) The expression of biologically active human p53 in Leishmania cells: a novel eukaryotic system to produce recombinant proteins. Nucleic Acids Res 23: 4073-080.
15. Reiner NE (1982) Host-parasite relationship in murine Leishmaniasis: pathophysiological and immunological changes. Infect Immun 38: 1223-1230.
16. Charest H, Zhang WW, Matlashewski G (1996) The developmental expression of Leishmania donovani A2 amastigotc-specific genes is post-transcriptionally mediated and involves elements located in the 3′-untranslated region. J Biol Chem 271: 17081-17090.
17. Zhang WW, Charest H, Ghedin E, Matlashewski G (1996) Identification and overexpression of the A2 amastigote-specific protein in Leishmania donovani. Mol Biochem Parasitol 78: 79-90.
18. Ghedin E, Dcbrabant A, Engel JC, Dwyer DM (2001) Secretary and endocytic pathways converge in a dynamic endosomal system in a primitive protozoan: Traffic 2: 175-188.
19. Kostelansky MS, Sun J, Lee S, Kim J, Ghirlando R, et al. (2006) Structural and functional organization ofthe ESCRT-I trafficking complex. Cell 125: 113-126.
20. Kostelansky MS, Schluter C, Tam YY, Lee S, Ghirlando R, et al. (2007) Molecular architecture and functional model of the complete yeast ESCRT-I heterotetramer. Cell 129: 485-498.
21. Cohen-Freue G, Holzer TR, Forney JD, McMaster WR (2007) Global gene expression in Leishmania. Int J Parasitol 37: 1077-1086.
22. Xie W, Li L, Cohen SN (1998) Cell cycle-dependent subcellular localization of the TSG101 protein and mitotic and nuclear abnormalities associated with TSG101 deficiency. Proc Natl Acad Sci USA 95: 1595-1600.
23. Ruland J, Sirard C, Elia A, MacPherson D, Wakeham A, et al. (2001) p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101. Proc Natl Acad Sci USA 98: 1859-1864.
24. Wagner KU, Krempler A, Qi Y, Park K, Henry MD, et al. (2003) Tsg101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues. Mol Cell Biol 23: 150-162.
25. Li L, Cohen SN (1996) Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell 85: 319-329.
26. Rao V, Fujiwara, N, Porcelli SA, Glickman MS (2005) Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med 4: 535-543.
27. Bankaitis VA, Malehorn DE, Emr SD, Greene R (1989) The Saccharomyces cerevisiae SEC14 gene encodes a cytosolic factor that is required for transport of secretory proteins from the yeast Golgi complex. J Cell Biol 108: 1271-1281.